Leucoencephalitis after recombinant hepatitis B vaccine

被引:4
作者
Manna, R [1 ]
DeSantis, A [1 ]
Oliviero, A [1 ]
Carnevale, A [1 ]
Caputo, S [1 ]
Pahor, M [1 ]
Laudisio, A [1 ]
Gasbarrini, G [1 ]
机构
[1] CATHOLIC UNIV,DEPT NEUROL,ROME,ITALY
关键词
D O I
10.1016/S0168-8278(96)80276-5
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:764 / 765
页数:2
相关论文
共 10 条
[1]   GENETIC PREDICTION OF NONRESPONSE TO HEPATITIS-B VACCINE [J].
ALPER, CA ;
KRUSKALL, MS ;
MARCUSBAGLEY, D ;
CRAVEN, DE ;
KATZ, AJ ;
BRINK, SJ ;
DIENSTAG, JL ;
AWDEH, Z ;
YUNIS, EJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 321 (11) :708-712
[2]  
Ebers G C, 1983, Neurol Clin, V1, P645
[3]   CENTRAL-NERVOUS-SYSTEM DEMYELINATION AFTER IMMUNIZATION WITH RECOMBINANT HEPATITIS-B VACCINE [J].
HERROELEN, L ;
DEKEYSER, J ;
EBINGER, G .
LANCET, 1991, 338 (8776) :1174-1175
[4]   SEQUENCE HOMOLOGY BETWEEN CERTAIN VIRAL-PROTEINS AND PROTEINS RELATED TO ENCEPHALOMYELITIS AND NEURITIS [J].
JAHNKE, U ;
FISCHER, EH ;
ALVORD, EC .
SCIENCE, 1985, 229 (4710) :282-284
[5]   DEFECTIVE FC-RECEPTOR FUNCTIONS ASSOCIATED WITH THE HLA-B8-DRW3 HAPLOTYPE - STUDIES IN PATIENTS WITH DERMATITIS-HERPETIFORMIS AND NORMAL SUBJECTS [J].
LAWLEY, TJ ;
HALL, RP ;
FAUCI, AS ;
KATZ, SI ;
HAMBURGER, MI ;
FRANK, MM .
NEW ENGLAND JOURNAL OF MEDICINE, 1981, 304 (04) :185-192
[6]   GUILLAIN-BARRE-SYNDROME AFTER MEASLES, MUMPS, AND RUBELLA VACCINE [J].
MORRIS, K ;
RYLANCE, G .
LANCET, 1994, 343 (8888) :60-60
[7]  
PENNER E, 1982, GASTROENTEROLOGY, V82, P576
[8]   POSTMARKETING SURVEILLANCE FOR NEUROLOGIC ADVERSE EVENTS REPORTED AFTER HEPATITIS-B VACCINATION - EXPERIENCE OF THE 1ST 3 YEARS [J].
SHAW, FE ;
GRAHAM, DJ ;
GUESS, HA ;
MILSTIEN, JB ;
JOHNSON, JM ;
SCHATZ, GC ;
HADLER, SC ;
KURITSKY, JN ;
HINER, EE ;
BREGMAN, DJ ;
MAYNARD, JE .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1988, 127 (02) :337-352
[9]   TRANSVERSE MYELITIS FOLLOWING HEPATITIS-B VACCINATION [J].
TREVISANI, F ;
GATTINARA, GC ;
CARACENI, P ;
BERNARDI, M ;
ALBERTONI, F ;
DALESSANDRO, R ;
ELIA, L ;
GASBARRINI, G .
JOURNAL OF HEPATOLOGY, 1993, 19 (02) :317-318
[10]  
1990, WHO DRUG INFORMATION, V4, P129